Used primarily as an intermediate in the synthesis of pharmaceutical compounds, particularly those targeting central nervous system disorders. Its structure allows for selective modifications that enhance binding affinity to certain receptors, making it valuable in developing drugs for neurological and psychiatric conditions. Commonly employed in research settings to explore new therapeutic agents for anxiety, depression, and neurodegenerative diseases. Also utilized in the preparation of receptor ligands due to its affinity for monoamine receptors.